Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. OncologyPRO
  2. Meeting Resources
  3. ESMO Immuno-Oncology Congress 2024

How genomic alterations drive resistance to IO

Role of the interferon pathway in genome integrity and drug response

Date

13 Dec 2024

Session

How genomic alterations drive resistance to IO

Topics

Cancer Biology;  Therapy;  Cancer Research

Tumour Site

Ovarian Cancer;  Breast Cancer

Presenters

Lorenza Penengo

Authors

L. Penengo

Author affiliations

  • Zurich/CH

Resources

This content is available to ESMO members and event participants.
Login

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.